A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arthritic Central Retinal Artery Occlusion (CRAO)

Conditions: Central Retinal Artery Occlusion Interventions: Drug: KUS121 high dose; Drug: KUS121 low dose; Drug: Sham procedure Sponsors: Kyoto Drug Discovery and Development Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials